Facebook
Twitter
LinkedIn
RSS

Investor Relations »

Home
About
Pipeline
Clinical Studies
- NIMH Clinical Study
- ELEVATE Clinical Study
VistaStem
Business Development
- Overview
- Strategic Partners
News & Media
Investors
Contact

News & Media

Press Releases
Media Coverage
Multimedia - Photos & Videos
Related Industry News

Multimedia - Photos & Videos

AV-101 Mechanism of Action Video

AV-101 Mechanism of Action Video

AV-101's Metabolite (7-Cl-KYNA) Inhibits NMDA Receptor Activity

Nasdaq Closing Bell Ceremony

Nasdaq Closing Bell Ceremony

Facebook Live Behind the Bell Interview @Nasdaq

Facebook Live Behind the Bell Interview @Nasdaq

Email Updates

Be the first to receive news, events & updates Sign Up

© 2018 VistaGen Therapeutics, Inc. All Rights Reserved.

Privacy Policy
Disclaimer
Sitemap